Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

CP, Cannon; DL, Bhatt; J, Oldgren; GYH, Lip; SG, Ellis; T, Kimura; M, Maeng; B, Merkely; U, Zeymer; S, Gropper; M, Nordaby; E, Kleine; R, Harper; J, Manassie; JL, Januzzi; Berg JM, Ten; PG, Steg; SH, Hohnloser

doi:10.1056/nejmoa1708454

Public

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Shared by NobleBlocks on Aug 27, 2017 • 12:00 AM UTC

Authors:

Cannon CP

Bhatt DL

Oldgren J

Abstract

<h4>Background</h4>Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the standard of care after percutaneous coronary intervention (PCI) for patients with atrial fibrillation, but this therapy is associated with a high risk of bleeding.<h4>Methods</h4>In this multicenter tr...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!